Sclerostin (SOST, Figure 3i) showed a very similar behavior to DKK-1, with a very significantly higher level in OM-positive patients compared to OM-negative ones, even with a lower AUC ROC (AUC = 0.819). Here, SOST is linked to ocular melanoma.